Savara Inc.
General ticker "SVRA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $621.6M (TTM average)
Savara Inc. follows the US Stock Market performance with the rate: 40.3%.
Estimated limits based on current volatility of 4.5%: low 5.94$, high 6.50$
Factors to consider:
- Total employees count: 28 as of 2022
- Top business risk factors: Operational and conduct risks, Third-party risks, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Current price 43.2% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.96$, 4.45$]
- 2025-12-31 to 2026-12-31 estimated range: [1.79$, 4.06$]
Financial Metrics affecting the SVRA estimates:
- Positive: with PPE of -6.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.19 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 80.54 > 63.39
- Positive: -14.38 < Investing cash flow per share per price, % of -6.36
Short-term SVRA quotes
Long-term SVRA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $38.84MM | $60.01MM | $103.20MM |
| Operating Income | $-38.84MM | $-60.01MM | $-103.20MM |
| Non-Operating Income | $1.38MM | $5.31MM | $7.32MM |
| Interest Expense | $0.09MM | $0.00MM | $0.00MM |
| R&D Expense | $27.88MM | $44.26MM | $78.03MM |
| Income(Loss) | $-37.46MM | $-54.70MM | $-95.88MM |
| Profit(Loss)* | $-38.15MM | $-54.70MM | $-95.88MM |
| Stockholders Equity | $107.78MM | $140.37MM | $171.45MM |
| Inventory | $2.05MM | $0.00MM | $0.00MM |
| Assets | $139.78MM | $177.56MM | $212.88MM |
| Operating Cash Flow | $-34.55MM | $-51.06MM | $-89.09MM |
| Capital expenditure | $0.01MM | $0.30MM | $0.03MM |
| Investing Cash Flow | $52.65MM | $-57.12MM | $-39.94MM |
| Financing Cash Flow | $0.09MM | $82.78MM | $117.58MM |
| Earnings Per Share** | $-0.25 | $-0.33 | $-0.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.